abstract |
The invention relates to a method for treating a patient who has an inflammatory disorder, administering to the patient (i) a tricyclic anti-depressant (e.g., amoxapine); and (ii) a corticosteroid (e.g., prednisolone) simultaneously or within 14 days of each other, in amounts sufficient to reduce or inhibit inflammation. |